Screen Reader Mode Icon
Congratulations. You have been selected as a potential partner for a clinical vaccination trial in COVID-19, which Exom Group is currently planning.

In order to be able to better assess which countries and trial sites can be included in the planned study so that it can be conducted as swiftly as possible, we need some information from you.

The feasibility survey will help us significantly in evaluating the current situation in different clinical trial markets. You can view the question catalog before you start filling in your answers.

Please consider that the study population is volunteers with limited exclusion criteria (preliminary In-/Ex-Criteria) and that a realistic assessment of the recruitment is highly important, as we require as many volunteers (=participants) as possible in a short period of time.

If you are covering multiple countries, please provide the information on a per-country level when answering the questions (e.g. expected investigator fee: xxx EUR/USD Country 1, xxx EUR/USD Country 2)

We already thank you in advance for your time and effort. In case of any questions, please feel free to contact us at

Your Exom Group Team.
0 of 34 answered